6-(3-Trifluoromethyl-phenylsulfanyl)-quinazoline-2,4-diamine

ID: ALA268089

Chembl Id: CHEMBL268089

Cas Number: 51123-99-0

PubChem CID: 100475

Max Phase: Preclinical

Molecular Formula: C15H11F3N4S

Molecular Weight: 336.34

Molecule Type: Small molecule

Names and Identifiers

Synonyms: WR-159412 | 51123-99-0|2,4-Diamino-6-(5-trifluoromethylphenyl)thioquinazoline|WR-159412|6-[3-(trifluoromethyl)phenyl]sulfanylquinazoline-2,4-diamine|ZAL3KJ3AZC|MLS003115820|WR 159412|6-((3-(trifluoromethyl)phenyl)thio)quinazoline-2,4-diamine|WR 159,412|NSC305782|NSC-305782|2,4-Quinazolinediamine, 6-((3-(trifluoromethyl)phenyl)thio)-|6-((3-(Trifluoromethyl)phenyl)thio)-2,4-quinazolinediamine|2,4-Quinazolinediamine, 6-[[3-(trifluoromethyl)phenyl]thio]-|NCIMech_000537|NSC 305782|UNII-ZAL3KJ3AZC|CHEShow More⌵

Canonical SMILES:  Nc1nc(N)c2cc(Sc3cccc(C(F)(F)F)c3)ccc2n1

Standard InChI:  InChI=1S/C15H11F3N4S/c16-15(17,18)8-2-1-3-9(6-8)23-10-4-5-12-11(7-10)13(19)22-14(20)21-12/h1-7H,(H4,19,20,21,22)

Standard InChI Key:  BFQQHTILCQZRGX-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA268089

   WR-159412

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 336.34

Molecular Weight (Monoisotopic): 336.0657

AlogP: 3.96

#Rotatable Bonds: 2

Polar Surface Area: 77.82

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.91

CX LogP: 4.11

CX LogD: 3.99

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.74

Np Likeness Score: -1.29

References

1. Ghose AK, Crippen GM..  (1983)  Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.,  26  (7): [PMID:6864738] [10.1021/jm00361a012]

2. Werbel LM, Degnan MJ..  (1987)  Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl)thio]quinazolines.,  30  (11): [PMID:3669022] [10.1021/jm00394a038]

3. Crippen GM..  (1980)  Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors.,  23  (6): [PMID:7392027] [10.1021/jm00180a004]

4. Battershell C, Malhotra D, Hopfinger AJ..  (1981)  Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.,  24  (7): [PMID:7277385] [10.1021/jm00139a009]

5. Ghose AK, Crippen GM..  (1982)  Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.,  25  (8): [PMID:7120278] [10.1021/jm00350a003]

6. Ghose AK, Crippen GM..  (1984)  General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.,  27  (7): [PMID:6737433] [10.1021/jm00373a016]

7. Prado-Prado FJ, García-Mera X, González-Díaz H..  (2010)  Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.,  18  (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068]

8. PubChem BioAssay data set, 

9. PubChem BioAssay data set, 

10. Elslager EF, Hutt MP, Jacob P, Johnson J, Temporelli B, Werbel LM, Worth DF, Rane L..  (1979)  Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.,  22  (10): [PMID:117107] [10.1021/jm00196a019]

11. Elslager EF, Jacob P, Johnson J, Werbel LM, Worth DF, Rane L..  (1978)  Folate antagonists. 13. 2,4-Diamino-6-](alpha,alpha,alpha-trifluoro-m-tolyl)thio]quinazoline and related 2,4-diamino-6-[(phenyl- and naphthyl)thio]quinazolines, a unique class of antimetabolites with extraordinary antimalarial and antibacterial effects.,  21  (10): [PMID:102792] [10.1021/jm00208a010]

12. Fukunaga JY, Hansch C, Steller EE..  (1976)  Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.,  19  (5): [PMID:1271401] [10.1021/jm00227a006]

13. Hansch C, Fukunaga JY, Jow PY..  (1977)  Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.,  20  (1): [PMID:319234] [10.1021/jm00211a020]

Source

Source(2):

• Scientific Literature
• PubChem BioAssays